New Irish system will link into the European verification network that is being set up to detect incidents of falsified medicines entering the supply chain using a "unique identifier" on most packs of prescription drugs, starting from February 2019.
Industry, pharmacist and wholesaler associations in Ireland are setting up a new not-for-profit body, the Irish Medicines Verification Organisation (IMVO), to implement and manage a national repository of "unique identifiers" that will have to be placed on the majority of prescription medicines from February 2019.
The Irish repository is one of a number of similar systems being set up around Europe that will...
The report gave examples of missed opportunities for innovation and patient access, as well as regulatory and operational problems that undermine the conduct of timely clinical trials in Europe.
The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.
Japan looks set to press ahead with a reimbursement price cut for Eisai's Alzheimer's drug Leqembi following a cost-effectiveness review, despite differences with the company over methodology.
